Page last updated: 2024-08-21

bufogenin and Innate Inflammatory Response

bufogenin has been researched along with Innate Inflammatory Response in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Gao, Y; Kang, Y; Li, W; Li, X; Liu, Z; Qi, Y; Xu, Z; Zhang, X	1

Other Studies

1 other study(ies) available for bufogenin and Innate Inflammatory Response

Article	Year
Resibufogenin, one of bufadienolides in toad venom, suppresses LPS-induced inflammation via inhibiting NF-κB and AP-1 pathways. International immunopharmacology, 2022, Volume: 113, Issue:Pt A Topics: Amphibian Venoms; Animals; Anti-Inflammatory Agents; Bufanolides; Inflammation; Interleukin-6; Ligands; Lipopolysaccharides; Mice; NF-kappa B; RAW 264.7 Cells; Transcription Factor AP-1; Tumor Necrosis Factor-alpha	2022

Article

Year

Resibufogenin, one of bufadienolides in toad venom, suppresses LPS-induced inflammation via inhibiting NF-κB and AP-1 pathways.

International immunopharmacology, 2022, Volume: 113, Issue:Pt A

Topics: Amphibian Venoms; Animals; Anti-Inflammatory Agents; Bufanolides; Inflammation; Interleukin-6; Ligands; Lipopolysaccharides; Mice; NF-kappa B; RAW 264.7 Cells; Transcription Factor AP-1; Tumor Necrosis Factor-alpha

2022